Supernus Pharmaceuticals Inc (SUPN)
Sales/Maturities of Investments
$1.36B
TTM · Period ending: · USD
SUPN Sales/Maturities of Investments
Latest reported$1.36Bperiod ending
Latest reported$1.36Bperiod ending
SUPN TTM Sales/Maturities of Investments ($26.87M → $1.36B)
TTM Sales/Maturities of Investments
High-resolution chart · PNG
SUPN sales/maturities of investments history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Sales/Maturities of Investments (USD) |
|---|---|
| 1,360,355,000 | |
| 1,413,097,000 | |
| 1,510,078,000 | |
| 868,141,000 | |
| 547,693,000 | |
| 512,739,000 | |
| 498,862,000 | |
| 401,486,000 | |
| 288,162,000 | |
| 273,167,000 | |
| 370,901,000 | |
| 352,847,000 | |
| 370,140,000 | |
| 401,870,000 | |
| 190,739,000 | |
| 551,152,000 | |
| 567,777,000 | |
| 509,857,000 | |
| 530,509,000 | |
| 211,547,000 | |
| 204,330,000 | |
| 374,644,000 | |
| 378,422,000 | |
| 388,124,000 | |
| 414,941,000 | |
| 259,384,000 | |
| 253,170,000 | |
| 219,023,000 | |
| 156,526,000 | |
| 119,627,000 | |
| 79,827,000 | |
| 50,876,000 | |
| 35,704,000 | |
| 30,860,000 | |
| 28,657,000 | |
| 32,478,000 | |
| 28,585,000 | |
| 29,564,000 | |
| 31,824,000 | |
| 26,308,000 | |
| 31,377,000 | |
| 36,250,000 | |
| 37,581,000 | |
| 45,157,000 | |
| 48,242,000 | |
| 53,108,000 | |
| 53,473,000 | |
| 70,127,000 | |
| 78,486,000 | |
| 72,036,000 | |
| 75,806,000 | |
| 79,718,000 | |
| 66,207,000 | |
| 62,041,000 | |
| 49,468,000 | |
| 17,394,000 | |
| 18,109,000 | |
| 18,814,000 | |
| 26,870,000 | |
| 40,492,308 | |
| 51,142,749 |